Dark
Light
Today: July 22, 2024
May 2, 2024
1 min read

imecxpand launches €300M fund to boost tech innovations in Belgium


TLDR:

  • Belgium-based imec.xpand has announced a new €300M fund to accelerate semiconductor and nanotechnology innovations.
  • The fund is established in collaboration with imec, focusing on breakthrough technologies like AI, ML, AR/VR, and photonics.

Belgium-based imec.xpand has launched a new €300M fund to accelerate the growth of transformative semiconductor and nanotechnology innovations. The fund, established in collaboration with imec, a world-leading R&D and innovation hub in nanoelectronics, aims to leverage imec’s expertise to target breakthrough technologies such as AI, ML, AR/VR, and photonics. The venture capital fund is dedicated to advancing the semiconductor industry by empowering startups to bring innovative technologies to market faster.

With a focus on life sciences, imec.xpand is also looking for opportunities to advance cell therapy, sequencing, neuromodulation, and other applications that have the potential to revolutionize medical diagnostics and treatments. The VC’s portfolio companies benefit from access to state-of-the-art cleanroom facilities, extensive networks, leading multi-disciplinary expertise, and the possibility for low-volume manufacturing.

Some notable portfolio companies of imec.xpand include Celestial AI, PsiQuantum, and Swave Photonics, each working on cutting-edge technologies in areas like optical computing, quantum computing, and holographic extended reality chip technology.

Imec.xpand is a global independent venture capitalist dedicated to early-stage semiconductor innovation. The company’s funds target ambitious deep tech startups where imec’s knowledge, expertise, and infrastructure can play a determining role in their growth. To date, the VC has invested in 23 companies that have raised almost €1.5B in financing, including two unicorns.


Previous Story

Imecxpand Unveils EUR 300M Fund in Global Semiconductor Race

Next Story

Ravi Kaushik appointed as Asia Investments Head at Flourish Ventures

Latest from Blog

Antheia Secures $17M Investment

TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
Go toTop